This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (20)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Bruce R. Bacon, MD; William H. Treuhaft, MD; Anita M. Goodman, MD

Arch Intern Med. 1981;141(2):223-226.

Abstract
• Two patients became severely pancytopenic while receiving azathioprine in low dosages for treatment of connective-tissue diseases. While mild hematologic complications are common with this drug, we believe that the degree of bone marrow suppression exhibited in these two patients is unusual, especially at the dosages (0.75 and 1.25 mg/kg/day) of azathioprine being used.

(Arch Intern Med 141:223-226, 1981)

Author Affiliations
From the Department of Medicine, Divisions of Hematology (Drs Bacon and Goodman) and Rheumatology (Dr Treuhaft), Case Western Reserve University School of Medicine at Cleveland Metropolitan General Hospital.

Footnotes
Accepted for publication March 17, 1980.

Reprint requests to Department of Medicine, Cleveland Metropolitan General Hospital, 3395 Scranton Rd, Cleveland, OH 44109 (Dr Bacon).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Moderate and severe neutropenia in patients with systemic lupus erythematosus
Martinez-Banos et al.
Rheumatology (Oxford) 2006;45:994-998.
ABSTRACT | FULL TEXT